The Effect of Mindfulness-Based Breathing Exercises on Symptom Control
1 other identifier
interventional
72
1 country
1
Brief Summary
This randomized controlled experimental study aims to evaluate the effect of mindfulness-based breathing exercises on symptom management and salivary cortisol levels in breast cancer patients receiving chemotherapy. The study population will consist of breast cancer patients undergoing chemotherapy treatment in the Oncology Department of Fırat University Hospital. A total of 72 patients who meet the inclusion criteria and volunteer to participate will be included in the study, with 36 patients in the experimental group and 36 in the control group. Data will be collected using the Personal Information Form and the Edmonton Symptom Assessment Scale. The findings of this study are expected to provide evidence regarding the effectiveness of mindfulness-based breathing exercises in improving symptom management and reducing stress levels in breast cancer patients receiving chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Mar 2026
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2026
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2026
March 16, 2026
March 1, 2026
3 months
March 11, 2026
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptom Severity
Evaluation of symptom severity in breast cancer patients receiving chemotherapy using the Edmonton Symptom Assessment Scale (ESAS).
Baseline and after the intervention period (e.g., 8 weeks)
Secondary Outcomes (1)
Salivary Cortisol Level
Baseline and after the intervention period (e.g., 8 weeks)
Study Arms (2)
Experimental Group
EXPERIMENTALBreast cancer patients receiving chemotherapy who will receive mindfulness-based breathing exercises in addition to routine care.
Control Group
NO INTERVENTIONBreast cancer patients receiving chemotherapy who will receive routine care only.
Interventions
Mindfulness-based breathing exercises focusing attention on breathing to promote awareness and support symptom management in breast cancer patients receiving chemotherapy.
Eligibility Criteria
You may qualify if:
- Being over 18 years of age
- Knowing their diagnosis
- Receiving chemotherapy for the first time due to a breast cancer diagnosis
- Having breast cancer stages I, II, or III (stage 4 patients were not included in the study as metastatic spread would increase symptoms and make communication with the patient difficult),
- Not receiving treatment for another cancer,
- Not having a physical disability that would prevent telephone interviews (hearing, speech),
- Not having any psychiatric disorder that would impair comprehension and understanding,
- Patients who have verbally and in writing consented to participate in the study will be included in the research.
You may not qualify if:
- Patients with communication problems • Patients with psychiatric problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Firat Universitylead
Study Sites (1)
Gül DURAL
Elâzığ, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
March 10, 2026
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
August 15, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share